Nanotechnology in imatinib delivery: Advancing cancer treatment through innovative nanoparticles

Nanotechnology offers promising approaches to enhance the delivery of Imatinib, a key drug for GIST, by improving its solubility, stability, and targeted distribution. These methods, including polymeric and lipid-based nanoparticles, aim to overcome imatinib's limitations and even facilitate co-delivery with other anticancer drugs. Addressing scalability and regulatory hurdles is crucial for translating this potential into standard GIST treatment.